EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy

Mohamed Said Ibrahim, Omar Ahmed Abdelwahab, Bashaer Elawfi, Fatmaelzahraa Yasser Ali, Sarah Amro, Shrouk F Mohammed, Nour Shaheen, Ahmed Negida, Martin Arndt, Mido Max Hijazi, Jochen Schaefer, Timo Siepmann

Neurological Sciences · 2025-05 · 46 (5) · 2249-2262

DOI: 10.1007/s10072-024-07939-1 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Neurological Sciences, online erschienen am 24.12.2024. Verfasst von Mohamed Said Ibrahim und 11 weiteren Autor:innen. Beteiligte Einrichtung: Dresden International University, Division of Medicine, Dresden, Germany. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität Dresden.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Duchenne muscular dystrophy (DMD) is a severe neuromuscular disorder, often leading to wheelchair dependence by age 13 with limited treatment options, largely relying on glucocorticosteroids. We assessed the efficacy and safety of vamorolone, a modified synthetic corticosteroid, for DMD.

Methods

We performed a systematic review and meta-analysis using seven databases including prospective studies comparing vamorolone with glucocorticosteroids or placebo in DMD patients. We extracted data on efficacy and safety outcomes. We built fixed effects models to assess mean differences. (PROSPERO: CRD42023396908).

Results

Out of 210 identified records, two study reports were included in meta-analysis providing data from 210 patients. Vamorolone at 2.0 mg/kg/day was associated with improvement time to climb four stairs velocity (MD = 0.05 95% CI [0.03 to 0.08] P = 0.0002), and time stand from supine velocity (MD = 0.07 95% CI [0.01 to 0.07] P = 0.007). A higher dose of 6.0 mg/kg/day was additionally associated with higher time to run/walk 10 m velocity (MD = 0.10 95% CI [-0.0.1 to 0.21] P = 0.07, I2 = 0%). Among these beneficial effects only improvement in time to climb four stairs velocity was sustained after a follow-up period of 30 months. Vamorolone did not inhibit growth but increased the risk of weight gain, suppression of adrenal function, and insulin resistance.

Conclusion

The results of our systematic review and meta-analyis are suggestive of improved efficacy and safety of vamorolone for DMD compared to standard glucocorticosteroids but the external validity of these findings as well as the medication’s long-term effects remain to be determined.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Muscular Dystrophy, DuchenneHumansTreatment OutcomePregnadienediols

Stichwörter der Autor:innen

6MWTDrugMuscleNSAASteroidTTCLIMBTTRWTTSTANDVamorolone

Substanzen

VBP15 compoundPregnadienediols

Autor:innen und Institutionen

  • Dresden International University, Division of Medicine, Dresden, Germany.
  • Medical Research Group of Egypt, Cairo, Egypt.
  • Medical Research Group of Egypt, Negida Academy, Arlington, MA, USA.
  • Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
  • Faculty of Medicine, Sana'a University, Sana'a, Yemen.
  • Faculty of Medicine, Zagazig University, Zagazig, Egypt.

Förderung

  • Technische Universität Dresden

Zitieren

APA

Ibrahim, M. S., Abdelwahab, O. A., Elawfi, B., Ali, F. Y., Amro, S., Mohammed, S. F., Shaheen, N., Negida, A., Arndt, M., Hijazi, M. M., Schaefer, J., & Siepmann, T. (2025). Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy. Neurological Sciences, 46(5), 2249-2262. https://doi.org/10.1007/s10072-024-07939-1

Vancouver

Ibrahim MS, Abdelwahab OA, Elawfi B, Ali FY, Amro S, Mohammed SF, et al. Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy. Neurological Sciences. 2025;46(5):2249-2262. doi:10.1007/s10072-024-07939-1

BibTeX
@article{Ibrahim2025,
  author = {Ibrahim, Mohamed Said and Abdelwahab, Omar Ahmed and Elawfi, Bashaer and Ali, Fatmaelzahraa Yasser and Amro, Sarah and Mohammed, Shrouk F and Shaheen, Nour and Negida, Ahmed and Arndt, Martin and Hijazi, Mido Max and Schaefer, Jochen and Siepmann, Timo},
  title = {Meta-analysis of the efficacy and safety of vamorolone in Duchenne muscular dystrophy},
  journal = {Neurological Sciences},
  year = {2025},
  volume = {46},
  number = {5},
  pages = {2249--2262},
  doi = {10.1007/s10072-024-07939-1}
}
Kostenlos starten →